Human and animal model studies revealed that AD is associated with reduced insulin levels in the CSF and with insulin resistance [142], as well as with lower levels of the insulin receptor substrate IRS1 and higher levels of p-IRS1, which is a marker of brain insulin resistance [143–145]. This evidence concerns the gene INS and Alzheimer disease.